Cariloop has been named to the 2026 Inc. 5000 list for the fifth consecutive year, ranking No. 2236 with 151% three-year revenue growth. DALLAS, Aug. 11, 2026 /PRNewswire-PRWeb/ -- Cariloop, a provider of employer-sponsored caregiving benefits, has been named to the 2026 Inc. 5000 list,...
Third consecutive recognition reflects the firm's investment in deeper client relationships, trial excellence, and national litigation leadership PITTSBURGH, Aug. 11, 2026 /PRNewswire-PRWeb/ -- Chaffin Luhana LLP has been named to the Inc. 5000 list of America's fastest-growing private...
Company Achieves 357% Three-Year Revenue Growth, Earning a Place Among the Nation's Most Successful Independent Businesses
Platform adds approximately one million users in eight months and has grown more than 370% since the NetSapiens acquisition
The executive behind Clio's rise from $100M to $500M ARR joins DoorLoop's board MIAMI, Aug. 11, 2026 /PRNewswire-PRWeb/ -- DoorLoop today announced the appointment of Ronnie Gurion to its board of directors. Gurion serves as President and COO of Clio, the legal technology platform where...
Partnership Enhances Eagle's Components Offering and Strengthens Its Position as a Complete Roofing System Solutions Provider. RIALTO, Calif., Aug. 11, 2026 /PRNewswire-PRWeb/ -- Under its expanding Secure Roof Components brand, Eagle Roofing Products is strengthening its commitment to...
The Google AI Professional Certificate is now the most popular gen AI program on Coursera, and we are expanding it with vibe coding.
Denver, Colorado--(Newsfile Corp. - August 11, 2026) - Experience Onward, founded by former NHL player and two time Stanley Cup champion Daniel Carcillo, today announced the acquisition of a private, 36 acre mountain property in Colorado that is now progressing through the state licensing process to become a legal psilocybin retreat destination.Named Onward Ranch, the property is being developed as a first of its kind residential retreat environment designed to bring legal, regulated psilocybin...
FDA Approval of Replimune's Intratumoral Therapy in Combination With Checkpoint Inhibition Reinforces Growing Momentum Behind Tumor-Directed Approaches Designed to Enhance Anti-Tumor Immune Response ATLANTA, GA - August 11, 2026 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and solid tumors, today highlighted the recent U.S. Food and Drug Administration (FDA) accelerated approval of Replimune Group, Inc.’s TUDRIQEV™ (formerly RP1) in combination with nivolumab as an important milestone in the evolution of intratumoral cancer immunotherapy. The FDA approved TUDRIQEV in combination with nivolumab for adults with unresectable advanced cutaneous melanoma whose disease has progressed fo
Google Health is teaming up with Abbott to give more holistic views of metabolic and women’s health.
Modern Recreational Technologies (MRT) restored the historic tennis courts at T.W. Andrews High School through a community volunteer initiative. Over 13 team members contributed 300+ volunteer hours to restore 17,000 square feet using Ramuc Clean & Prep Solution and 280 gallons of Tuff Court®, helping prepare the facility for the return of the school's tennis program while providing hands-on technical training for MRT [PR.com]
Veteran customer success leader joins PCMI as the company scales customer success alongside a growing customer base and expanding AI capabilities. PARK RIDGE, Ill., Aug. 11, 2026 /PRNewswire-PRWeb/ -- PCMI, the leading provider of cloud-based administration software for F&I products and...